ETF - 美股 | etnet 經濟通|香港新聞財經資訊和生活平台

26,111.84

+432.06

(+1.68%)

25,896

-44

(-0.17%)

低水216

8,805.60

+160.79

(+1.86%)

4,910.02

+82.83

(+1.72%)

2,582.81億

4,107.51

+28.87

(+0.708%)

4,810.35

+52.14

(+1.096%)

15,120.92

+290.46

(+1.959%)

2,803.94

+25.80

(+0.93%)

77,293.0600

+950.2800

(1.245%)

人民幣最佳客戶買入價

1.0954

澳元最佳客戶買入價

5.1002

歐元最佳客戶買入價

9.1277

英鎊最佳客戶買入價

10.4269

日圓最佳客戶買入價

4.9182

／

i

按可檢視更多數據

代號	名稱	貨幣	按盤價	今日升跌	成交金額	市值	1分鐘圖
ASHR	Xtrackers Harvest CSI 300 China A-Shares ETF	USD	34.630 盤前34.990	-0.259% +1.040%	4.77千萬 9,384.11	17.31億
ASHS	Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF	USD	43.080	-1.644%	5.86萬	3.72千萬
CHIQ	Global X MSCI China Consumer Discretionary ETF	USD	19.580	-1.086%	22.81萬	1.68億
CNXT	VanEck ChiNext ETF	USD	50.800	-0.821%	1.12千萬	7.17千萬
CNYA	iShares MSCI China A ETF	USD	36.250	-0.434%	6.10百萬	2.35億
CQQQ	Invesco China Technology ETF	USD	49.370	-1.732%	1.04千萬	26.90億
CXSE	WisdomTree China ex-State-Owned Enterprises Fund	USD	39.507	-0.715%	21.35萬	5.16億
FCA	First Trust China AlphaDEX Fund	USD	32.825	0.051%	1.15百萬	1.16億
FLCH	Franklin FTSE China ETF	USD	22.720	-1.002%	1.04千萬	2.85億
FXI	iShares China Large-Cap ETF	USD	36.250 盤前36.670	-0.549% +1.159%	2.19億 62.52萬	60.80億
FXP	Proshares Trust Ultrashort Ftse China 50	USD	20.000	1.466%	2.54萬	5.64百萬
GXC	State Street SPDR S&P China ETF	USD	94.460	-0.767%	2.74百萬	4.81億
JCHI	JPMorgan Active China ETF	USD	54.625	-0.168%	4.83萬	1.50千萬
KBA	KraneShares Bosera MSCI China A 50 Connect Index ETF	USD	32.750	-0.395%	55.41萬	1.89億
KGRN	KraneShares MSCI China Clean Technology Index ETF 創1個月低	USD	28.250	-1.452%	62.59萬	6.31千萬
KLIP	KraneShares KWEB Covered Call Strategy ETF	USD	26.267	-0.368%	44.44萬	1.14億
KSTR	KraneShares SSE STAR Market 50 Index ETF	USD	21.230	-1.667%	1.11百萬	9.17千萬
KURE	KraneShares MSCI All China Health Care Index ETF	USD	17.205	1.381%	9,244.94	8.06千萬
KWEB	KraneShares CSI China Internet ETF	USD	28.110 盤前28.418	-0.882% +1.095%	2.25億 8.97萬	62.68億
MCH	Matthews China Active ETF	USD	27.840	-0.927%	1.44萬	2.25千萬

最新

人氣

etnet TV

財經新聞

評論

專題透視

生活

DIVA

健康好人生

香港好去處